Amphastar Pharmaceuticals
AMPH
#6096
Rank
HK$7.19 B
Marketcap
HK$154.78
Share price
-5.62%
Change (1 day)
-27.69%
Change (1 year)

Market capitalization of Amphastar Pharmaceuticals (AMPH)

Market cap: HK$7.19 Billion

As of March 2026 Amphastar Pharmaceuticals has a market cap of HK$7.19 Billion. This makes Amphastar Pharmaceuticals the world's 6096th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amphastar Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$7.19 B-26.65%
2025HK$9.81 B-30.47%
2024HK$14.10 B-39.03%
2023HK$23.14 B118.71%
2022HK$10.58 B21.77%
2021HK$8.68 B17.36%
2020HK$7.40 B5.82%
2019HK$6.99 B-3.71%
2018HK$7.26 B5.15%
2017HK$6.91 B5.13%
2016HK$6.57 B31.87%
2015HK$4.98 B23.99%
2014HK$4.02 B

End of Day market cap according to different sources

On Mar 2nd, 2026 the market cap of Amphastar Pharmaceuticals was reported to be:

HK$7.44 Billion
by Nasdaq info icon info icon
HK$7.62 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Tonix Pharmaceuticals
TNXP
HK$1.39 B-80.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
HK$0.24 B-96.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
HK$0.23 B-96.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
HK$81.37 M-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA